1 / 29

Dosing Regimen Design

Dosing Regimen Design. Multiple Dosing: Intermittent or multiple dose regimen. 100 mg q. t 1/2 via i.v. bolus. 200. 150. Amount in Body [mg]. 100. 50. Time [t 1/2 ]: 1 2 3 4 5 6. Principle: 1 dose lost per .

laurie
Télécharger la présentation

Dosing Regimen Design

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Dosing Regimen Design Multiple Dosing: Intermittent or multiple dose regimen

  2. 100 mg q. t1/2 via i.v. bolus 200 150 Amount in Body [mg] 100 50 Time [t1/2]: 1 2 3 4 5 6

  3. Principle: 1 dose lost per  At steady state, Rate In = Rate Out F•Dose = Ass,max - Ass,min Ass,min = Ass,maxe-KE F•Dose = Ass,max (1 - e-KE) Ass,max = F•Dose /(1 - e-KE) Ass,min = Ass,max - F•Dose

  4. AN,max & AN,min N = 1 2 3 4 5 6 7 Not AN,min = AN,max - F•Dose Why?

  5. Css,max & Css,min

  6. Average amount of drug in the body at steady state At steady state, Rate In = Rate Out FDose/ = KE Ass,av 1/KE = t1/2/ln 2 = 1.44 t1/2

  7. Average steady-state plasma concentration

  8. AUC Equal Areas

  9. Css,av Concept applies to all routes of administration and it is independent of absorption rate.

  10. Dosing rate from AUC0- Given AUC after a single dose, D, the maintenance dose, DM , is: Where D produced the AUC0-, Css,av is the desired steady-state plasma concentration, and  is the desired dosing interval.

  11. Example: 50 mg p.o. dose 2 3 2.4 1.8 Cp mg/L 1 2 4 8 Time [h] AUC = 1+2.5+5.4+8.4+6 = 23.3 mg•h/L

  12. Example, continued Calculate a dosing regimen for this drug that would provide an average steady-state plasma concentration of 15 mg/L. DM = 193 mg Dosing regimen: 200 mg q. 6 h.

  13. Example, continued - 2 There is a problem with this approach ?? Peak and trough concentrations are unknown. Css,max Css,min

  14. Another example - digitoxin t1/2 = 6 days; usual DR is 0.1 mg/day Assuming rapid and complete absorption of digitoxin, Ass,av = 1.44 F Dose t1/2/ = (1.44)(1)(0.1mg/d)(6d)/(1d) = 0.864 mg What would be the average steady-state body level? Maximum and minimum plateau values? Ass,max = 0.1/(1-e-(0.116)(1)) = 0.909 mg Is there accumulation of digitoxin? Ass,min = 0.909 – 0.1 = 0.809 mg How long to reach steady state?

  15. KE AI  KE FI Rate of Accumulation, AI, FI The rate of accumulation depends on the half-life of the drug: 3.3 x t1/2 gives 90% of the steady-state level. Accumulation Index (AI): Ass,max/F DM = (1 – e-KE)-1 Fluctuation Index (FI): Ass,max/Ass,min = e+KE When  = t1/2 AI = FI = 2

  16. ka v CL Absorption Rate influence on Rate of Accumulation KE = 0.1

  17. When ka >> KE, control is by drug t1/2: When ka << KE, control is by absorption t1/2:

  18. Loading Dose (LD) = Ass,max F Whether a LD is needed depends upon: • Accumulation Index • Therapeutic Index • Drug t1/2 • Patient Need

  19. Cp Time Dosing Regimen Design OBJECTIVE: Maintain Cp within the therapeutic window.

  20. Cu Cp Cl max Time Dosing Regimen Design APPROACH: Calculate max and DM,max.

  21. Cp Time DM,max and Dosing Rate From the principle that one dose is lost over a dosing interval at steady state: DM,max = (V/F)(Cu - Cl) The Dosing Rate (DR) is DM,max max

  22. KEV = CL (Cu - Cl)/ln(Cu/Cl) = Css,av = logarithmic average of Cu and Cl. The log average is the concentration at the midpoint of the dosing interval; it’s less than the arithmetic average. DR = (CL/F)Css,av

  23. Average Concentration Approach • Choose the average to maintain: Css,av = (Cu - Cl)/ln (Cu/Cl) • Choose : max ;usually 4, 6, 8, 12, 24 h • Calculate DR: DR = (CL/F)Css,av • Calculate DM: DM = DR•

  24. Example Css,av = (10 – 3)/ln (10/3) = 5.8 mg/L max = (1.44)(4.85)[ln (10/3)] = 8.41 h Choose  < max: 8 h DR = (5 L/h)(5.8 mg/L)/(0.8) = 36.25 mg/h DM = (36.25 mg/h)(8 h) = 290 mg  300 mg Dosing Regimen: 300 mg q 8 h

  25. Peak Concentration Approach • Choose the peak concentration to maintain. • Choose : max ;usually 4, 6, 8, 12, 24 h • Calculate DM: DM = (V•Cpeak/F)(1 - e-KE) from:

  26. Example Cpeak = 8 mg/L max = (1.44)(4.85)[ln (10/3)] = 8.41 h Choose  < max: 6 h  set to 6 h so that Css,min > Cl DM = [(35 L)(8 mg/L)/0.8](1 – e-(0.143)(6)) = 202 mg Dosing Regimen: 200 mg q 6 h

  27. Check Css,max = [(0.8)(200)/35]/(1 – e-(0.143)(6)) = 7.93 mg/l Css,min = 7.93 - (0.8)(200)/35 = 3.4 mg/L

  28. Rationale for controlled release dosage forms • Compliance vs. fluctuation: when the dosing interval is less than 8 h, compliance drops. • For short half-life drugs, either  must be small (2, 3, 4, 6 h), or the fluctuation must be quite large, when conventional dosage forms are used. • Use of controlled release permits long  while maintaining low fluctuation. • Not generally of value for drugs with long half lives (> 12 h). Due to extra expense, they should not be recommended.

  29. Assessment of PK parameters CL: CL/F = (DM/)/Css,av and Css,av = AUCss,/ Relative F: CLR: CLR = (Ae,ss/ x Css,av) where Ae,ss is the amount of drug excreted in the urine over one .

More Related